Cost-Effectiveness Analysis of Abiraterone in Patients with Metastatic, Castration-Resistant, Prostate Cancer with Progression after Receiving Chemotherapy with Docetaxel, Compared with Receiving only Palliative Support- The Perspective of ...
Abstract
Authors
H Marin Piva JA Castro Cordero E Sabater Cabrera